FDA Approved: ICATIBANT — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's generic icatibant (ANDA 208317) for the treatment of acute attacks of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

ORIG AP for ICATIBANT (ICATIBANT)